Clinical Trial Update: POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating genotype-guided clopidogrel monotherapy for Acute Coronary Syndrome patients with CYP2C19 polymorphism is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: St. Antonius Hospital | Conditions: Acute Coronary Syndrome, CYP2C19 Polymorphism | Phase 2 | Status: RECRUITING